Scientists at the Dr. Rath Research Institute in California have published a groundbreaking study in the American Journal of Cardiovascular Disease proving that heart disease is an early form of the vitamin C deficiency disease scurvy. Building on a discovery made by Dr. Matthias Rath in the early 1990s, this publication deals a major blow to the cholesterol theory of heart disease and the pharmaceutical industry’s associated $30 billion annual sales in patented cholesterol-lowering statin drugs.
In this latest research, transgenic mice were used that mimic human metabolism with regard to two distinct genetic features: an inability to produce vitamin C, and the ability to produce Lipoprotein(a). When given a diet containing an insufficient amount of vitamin C, the mice were found to deposit Lipoprotein(a) in their vascular walls and develop atherosclerosis. The degree to which they developed heart disease was found to be inversely related to their intake of vitamin C. Mice with the highest intake of vitamin C had the lowest depositions of Lipoprotein(a) in their arteries and the least atherosclerotic lesion development.